Data protection

数据保护
  • 文章类型: English Abstract
    Digital assistants have become an indispensable tool in modern cardiology. The associated technological progress offers a significant potential to increase the efficiency of medical processes, enable more precise diagnoses in a shorter time, and thus improve patient care. However, the integration of digital assistants into clinical cardiology also raises new challenges and questions, particularly regarding the handling of legal issues. This review article aims to raise awareness of individual legal issues resulting from the use of digital technologies in cardiology. The focus is on how to deal with various legal challenges that cardiologists face, including issues related to treatment freedom, professional confidentiality and data protection. The integration of digital assistants in cardiology leads to a noticeable improvement in efficiency and quality of patient care, but at the same time, it involves a variety of legal challenges that need to be carefully addressed.
    UNASSIGNED: Digitale Helfer sind inzwischen ein unverzichtbares Werkzeug in der modernen Kardiologie. Der damit einhergehende technologische Fortschritt bietet hierbei ein ausgesprochenes Potenzial, die Effizienz medizinischer Prozesse zu steigern, in kürzester Zeit präzisere Diagnosen zu ermöglichen und damit die Patientenversorgung zu verbessern. Doch mit der zunehmenden Integration digitaler Helfer im sonst arbeitsintensiven kardiologischen Berufsalltag ergeben sich auch neue Herausforderungen und Fragestellungen, insbesondere im Hinblick auf den Umgang mit dem Thema Recht. Der vorliegende Übersichtsartikel zielt darauf ab, ein Bewusstsein für einzelne juristische Themen zu schaffen, die aus der Verwendung digitaler Technologien in der Kardiologie resultieren. Dabei wird es im Kern um den wohlüberlegten Umgang mit den haftungsrechtlichen Themen der Therapiefreiheit, des kardiologischen Facharztstandards, der ärztlichen Schweigepflicht wie auch des Datenschutzes gehen. Die Integration digitaler Helfer in der Kardiologie führt insgesamt zu einer spürbaren Verbesserung der Effizienz und Qualität der Patientenversorgung, beinhaltet jedoch gleichzeitig eine Vielzahl rechtlicher Herausforderungen, die sorgfältig adressiert werden müssen.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    人工智能(AI)在麻醉中的潜在应用是广泛的。~然而,像任何技术进步一样,人工智能在麻醉实践中的整合既有好处,也有潜在的风险。本文旨在阐明在麻醉领域使用AI技术的一些优点和缺点。在麻醉中应用AI的好处包括改善围手术期风险分层,麻醉计划的个性化,提高效率,最终降低医疗成本。然而,对技术的依赖可能会降低临床敏锐度,但此外,还有围绕数据质量的问题,隐私以及法律和道德问题,这需要进一步评估。虽然麻醉实践中的AI拥有巨大的前景,有大量的挑战需要仔细考虑和持续评估。需要医护人员采取协作方式,开发商和监管机构推广保险箱,负责任,人工智能在麻醉实践中的有效应用。
    The potential applications of Artificial Intelligence (AI) in anaesthesia are expansive.~However, like any technological advancement, the integration of AI in anaesthetic practice comes with both benefits and potential risks. This article seeks to set out some of the advantages and disadvantages of the use of AI technologies within the field of anaesthesia. Benefits of the application of AI in anaesthesia include an improvement in perioperative risk stratification, personalisation of anaesthetic plans, improvement in efficiency and ultimately reduce healthcare costs. However, reliance on technology may reduce clinical acumen but furthermore there are issues surrounding data quality, privacy as well as legal and ethical concerns, which require further evaluation. Whilst AI within anaesthetic practice holds immense promise, there are substantial challenges which require careful consideration and ongoing evaluation. A collaborative approach will be required from healthcare staff, developers and regulators to promote the safe, responsible, and effective application of AI in anaesthesia practice.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:社交媒体平台越来越多地用于招募患者进行临床研究。然而,患者对社交媒体招募的态度研究不足。
    目的:这项混合方法研究旨在评估乙型肝炎患者接受社交媒体招募的预测因素,在这种情况下被认为特别脆弱的患者群体。
    方法:使用混合方法方法,我们调查的假设是基于对6例乙型肝炎患者和30名多学科专家的定性访谈研究而制定的.将主题分析法应用于定性访谈分析。对于横断面调查,我们还从德国3个临床中心招募了195例乙型肝炎患者.在数据收集期间,能够判断乙型肝炎诊断的成年患者了解德语并访问了3个研究中心中的1个,有资格参加。数据分析使用SPSS(28版;IBM公司)进行,包括描述性统计和回归分析。
    结果:在定性访谈分析的基础上,我们假设6个因素与接受社交媒体招聘相关:在乙型肝炎的背景下使用社交媒体(假设1),数字素养(假设2),对临床研究的兴趣(假设3),对非医学(假设4a)和医学(假设4b)信息源的信任,将乙型肝炎诊断视为秘密(假设5a),社交媒体背景下对数据隐私的态度(假设5b),和感知的污名(假设6)。回归分析显示,乙型肝炎的社交媒体使用率越高(假设1),对临床研究的兴趣越高(假设3),对非医疗信息源的信任越多(假设4a),乙型肝炎诊断的保密性越低(假设5a),更高的接受社会媒体作为招募工具的临床乙型肝炎研究。
    结论:这项混合方法研究为乙型肝炎患者临床研究招募提供了对社交媒体接受的第一个定量见解。该研究仅限于德国的乙型肝炎患者,但旨在成为未来研究的参考点,评估对社交媒体招募的态度和接受临床研究。这样的实证调查可以促进设计临床研究以及伦理审查委员会的研究人员的工作,以特定环境的方式平衡社交媒体招聘的风险和收益。
    BACKGROUND: Social media platforms are increasingly used to recruit patients for clinical studies. Yet, patients\' attitudes regarding social media recruitment are underexplored.
    OBJECTIVE: This mixed methods study aims to assess predictors of the acceptance of social media recruitment among patients with hepatitis B, a patient population that is considered particularly vulnerable in this context.
    METHODS: Using a mixed methods approach, the hypotheses for our survey were developed based on a qualitative interview study with 6 patients with hepatitis B and 30 multidisciplinary experts. Thematic analysis was applied to qualitative interview analysis. For the cross-sectional survey, we additionally recruited 195 patients with hepatitis B from 3 clinical centers in Germany. Adult patients capable of judgment with a hepatitis B diagnosis who understood German and visited 1 of the 3 study centers during the data collection period were eligible to participate. Data analysis was conducted using SPSS (version 28; IBM Corp), including descriptive statistics and regression analysis.
    RESULTS: On the basis of the qualitative interview analysis, we hypothesized that 6 factors were associated with acceptance of social media recruitment: using social media in the context of hepatitis B (hypothesis 1), digital literacy (hypothesis 2), interest in clinical studies (hypothesis 3), trust in nonmedical (hypothesis 4a) and medical (hypothesis 4b) information sources, perceiving the hepatitis B diagnosis as a secret (hypothesis 5a), attitudes toward data privacy in the social media context (hypothesis 5b), and perceived stigma (hypothesis 6). Regression analysis revealed that the higher the social media use for hepatitis B (hypothesis 1), the higher the interest in clinical studies (hypothesis 3), the more trust in nonmedical information sources (hypothesis 4a), and the less secrecy around a hepatitis B diagnosis (hypothesis 5a), the higher the acceptance of social media as a recruitment tool for clinical hepatitis B studies.
    CONCLUSIONS: This mixed methods study provides the first quantitative insights into social media acceptance for clinical study recruitment among patients with hepatitis B. The study was limited to patients with hepatitis B in Germany but sets out to be a reference point for future studies assessing the attitudes toward and acceptance of social media recruitment for clinical studies. Such empirical inquiries can facilitate the work of researchers designing clinical studies as well as ethics review boards in balancing the risks and benefits of social media recruitment in a context-specific manner.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    SARS-CoV-2大流行强调了快速,生物医学合作研究。在ORCHESTRA财团中,我们在时间紧迫的条件下,以最少的培训和维护工作迅速部署了假名服务,以支持复杂的,多站点研究项目。两年多了,该服务已部署在11个国家的13个地点,登记了10,000多名研究参与者和15,000个生物样本。在这项工作中,作为这个过程的一部分,我们提出了经验教训。最重要的是,我们了解到,通过创造性地利用广泛可用的工具,可以克服共同的挑战,并且有一个专门的合作伙伴来管理软件推出和为每个站点预先配置软件包,可以促进有效的实施。
    The SARS-CoV-2 pandemic highlighted the importance of fast, collaborative research in biomedicine. Within the ORCHESTRA consortium, we rapidly deployed a pseudonymization service with minimal training and maintenance efforts under time-critical conditions to support a complex, multi-site research project. Over two years, the service was deployed in 13 sites across 11 countries to register more than 10,000 study participants and 15,000 biosamples. In this work, we present lessons learned as part of this process. Most importantly, we learned that common challenges can be overcome by creatively utilizing widely available tools and that having a dedicated partner to manage software rollout and pre-configure software packages for each site fosters the effective implementation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: English Abstract
    Clinical imaging uses a variety of medical imaging techniques to diagnose and monitor diseases, injuries and other health conditions. These include X‑ray images, computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound. These procedures are used to make accurate diagnoses and plan the best possible treatment for patients. Forensic imaging, in contrast, is used in both living and deceased persons in the context of criminal investigations. Postmortem forensic imaging techniques, such as postmortem CT (PMCT) and postmortem CT angiography (PMCTA), include some of the same procedures used in clinical imaging. An important difference between clinical and forensic imaging is the purpose and context in which the imaging studies are used. In addition, radiological procedures, such as angiography, need to be adapted and modified in the post-mortem setting. From a legal perspective clinical and forensic imaging must strictly adhere to privacy and procedural guidelines. Forensic images often need to be admissible as evidence in court, which places specific requirements on the quality, authenticity and documentation of images. In the case of living individuals, there must be a valid indication and consent from the patient. Consent must also fundamentally be obtained for post-mortem examinations, e.g. from the public prosecutor\'s office.
    UNASSIGNED: In der klinischen Bildgebung werden verschiedene medizinische Bildgebungsverfahren eingesetzt, um Krankheiten, Verletzungen und andere Gesundheitszustände zu diagnostizieren und zu überwachen. Dazu gehören unter anderem Röntgenaufnahmen, Computertomographie (CT), Magnetresonanztomographie (MRT) und Ultraschall. Diese Verfahren werden genutzt, um genaue Diagnosen zu stellen und die bestmögliche Behandlung für die Patienten zu planen. Die forensische Bildgebung wird im Gegensatz dazu für lebende als auch verstorbene Personen im Rahmen strafrechtlicher Ermittlungen genutzt. Postmortale forensische Bildgebungstechniken, wie postmortale CT (PMCT) und postmortale CT-Angiographien (PMCTA) umfassen teils gleiche Verfahren wie in der klinischen Bildgebung. Ein wichtiger Unterschied zwischen klinischer und forensischer Bildgebung liegt in der Zielsetzung und dem Kontext, in dem die Bilder verwendet werden. Zudem müssen die radiologischen Verfahren, beispielsweise die Angiographie, im postmortalen Setting angepasst und modifiziert werden. In rechtlicher Hinsicht müssen bei der klinischen und der forensischen Bildgebung strenge Datenschutz- und Verfahrensrichtlinien eingehalten werden. Forensische Bilder müssen oft vor Gericht als Beweismittel zugelassen werden können, was spezifische Anforderungen an die Qualität, Authentizität und Dokumentation der Bilder stellt. Bei Lebenden müssen insbesondere eine rechtfertigende Indikation sowie die Einwilligung des Patienten vorliegen. Auch für die postmortale Untersuchung muss grundsätzlich eine Einwilligung, beispielsweise durch die Staatsanwaltschaft, vorliegen.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    真实世界证据(RWE)研究是对患者的数据进行的,这些数据主要用于监测患者的健康状况。使用现实世界的数据在学术研究或监管提交中生成证据会引发各种道德问题,例如隐私,保密性,数据保护,数据去识别,数据共享,研究的科学设计,和知情同意要求。在规划和开展RWE研究时,研究人员和赞助者应遵守当前的道德标准。伦理委员会应在批准之前考虑RWE研究特有的伦理问题。
    Real-world evidence (RWE) studies are conducted on patient\'s data primarily collected for monitoring of health status of patients. The use of real-world data to generate evidence in academic research or for regulatory submission raises a variety of ethical issues such as privacy, confidentiality, data protection, data de-identification, data sharing, scientific design of study, and informed consent requirements. The investigators-researchers and sponsors should adhere to current standards of ethics whilst planning and conduct of RWE studies. The ethics committees should consider ethical issues specific to RWE studies before approval.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    BACKGROUND: The demand for chat messaging apps for communication between physicians, therapists and patients is increasing. The expectations for this form of communication and uncertainties regarding introduction and use are heterogeneous.
    OBJECTIVE: The implementation of chat messengers in the care of patients with Parkinson\'s disease should be facilitated by recommendations regarding introduction and usage.
    METHODS: Semi-structured interviews with neurologists and physiotherapists were conducted to capture the expectations and needs regarding the use of chat messengers. From the data analysis, recommendations were derived.
    RESULTS: The expectations for technical functionality exceeded the chat messenger functions. This concerns, e.g., the connection of the chat messenger to the electronic patient file. There is a great deal of uncertainty, particularly when it comes to the applicable General Data Protection Regulations (GDPR). The recommendations relating to the use of chat messengers, data protection aspects, the design of such tools and methodological considerations can help to implement the tool as an additional communication channel.
    CONCLUSIONS: Practical recommendations regarding functionality, the use of chat messengers in everyday life and in relation to data protection are derived from the results. By improving knowledge, physicians and therapists can contribute to the successful establishment of chat messengers as an additional communication tool.
    UNASSIGNED: HINTERGRUND: Die Nachfrage nach Chat-Messengern für den Austausch zwischen Ärzten, Therapeuten und ihren Patienten steigt. Die Erwartungen an die Chat-Messenger und Unsicherheiten hinsichtlich Einführung und Nutzung sind heterogen.
    UNASSIGNED: Die Implementierung eines Chat-Messengers in die Parkinson-Versorgung soll durch die Formulierung einführungs- und anwendungsrelevanter Empfehlungen vereinfacht werden.
    METHODS: Semistrukturierte Interviews mit Neurologen und Physiotherapeuten wurden durchgeführt, um die Erwartungen an die Nutzung von Chat-Messengern zu erfassen, welche die Basis für die abgeleiteten Empfehlungen bildeten.
    UNASSIGNED: Die Erwartungen an die technische Funktionalität übersteigen die Funktionen von Chat-Messenger. Das betrifft z. B. die Anbindung des Chat-Messengers an die elektronische Patientenakte. Insbesondere auch bei den anzuwendenden Regelungen der Datenschutz-Grundverordnung (DSGVO) herrscht große Unsicherheit. Die Empfehlungen, die sich auf die Nutzung der Chat-Messenger, auf die Aspekte des Datenschutzes, die Gestaltung dieser Technologien und methodische Überlegungen beziehen, sollen bei der Implementierung des Tools als zusätzlichen Kommunikationskanal helfen.
    CONCLUSIONS: Aus den Ergebnissen leiten sich Empfehlungen zur Funktionalität, dem Umgang mit Chat-Messengern im Alltag und in Bezug zum Datenschutz ab. Durch Verbesserung der Kenntnisse bei den Gesundheitsberuflern und Beachtung dieser Handlungsanweisungen können Ärzte und Therapeuten zu einer erfolgreichen Etablierung des Chat-Messengers als zusätzliches Kommunikationstool beitragen.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    这篇观点文章首先探讨了在医学教育背景下与未来大语言模型(LLM)应用相关的道德挑战。这些挑战不仅包括与LLM发展相关的伦理问题,比如人工智能(AI)幻觉,信息偏差,隐私和数据风险,以及透明度和可解释性方面的缺陷,但也涉及LLM的应用问题,包括情商的不足,教育不平等,学术诚信问题,以及责任和版权所有权问题。然后,本文分析了现有的与AI相关的法律和道德框架,并强调了它们在医学教育背景下应用LLM的局限性。为了确保LLM以负责任和安全的方式集成,作者建议开发专门为该领域的LLM量身定制的统一道德框架。该框架应基于八项基本原则:质量控制和监督机制;隐私和数据保护;透明度和可解释性;公平和平等待遇;学术诚信和道德规范;问责制和可追溯性;保护和尊重知识产权;以及促进教育研究和创新。作者进一步讨论了实施这些原则可以采取的具体措施,从而为发展一个全面和可行的道德框架奠定了坚实的基础。基于这八个基本原则的这种统一的道德框架可以为LLM在医学教育中的应用提供明确的指导和支持。这种方法可以帮助在技术进步和道德保障之间建立平衡,从而确保医学教育能够在不损害公平原则的情况下进步,正义,或患者安全,建立更公平的,更安全,以及更有效的医学教育环境。
    This viewpoint article first explores the ethical challenges associated with the future application of large language models (LLMs) in the context of medical education. These challenges include not only ethical concerns related to the development of LLMs, such as artificial intelligence (AI) hallucinations, information bias, privacy and data risks, and deficiencies in terms of transparency and interpretability but also issues concerning the application of LLMs, including deficiencies in emotional intelligence, educational inequities, problems with academic integrity, and questions of responsibility and copyright ownership. This paper then analyzes existing AI-related legal and ethical frameworks and highlights their limitations with regard to the application of LLMs in the context of medical education. To ensure that LLMs are integrated in a responsible and safe manner, the authors recommend the development of a unified ethical framework that is specifically tailored for LLMs in this field. This framework should be based on 8 fundamental principles: quality control and supervision mechanisms; privacy and data protection; transparency and interpretability; fairness and equal treatment; academic integrity and moral norms; accountability and traceability; protection and respect for intellectual property; and the promotion of educational research and innovation. The authors further discuss specific measures that can be taken to implement these principles, thereby laying a solid foundation for the development of a comprehensive and actionable ethical framework. Such a unified ethical framework based on these 8 fundamental principles can provide clear guidance and support for the application of LLMs in the context of medical education. This approach can help establish a balance between technological advancement and ethical safeguards, thereby ensuring that medical education can progress without compromising the principles of fairness, justice, or patient safety and establishing a more equitable, safer, and more efficient environment for medical education.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    Artificial intelligence (AI) is a tool that is only as good as its user. In the case of humanoid robots, an AI system can be seen as a social counterpart. Decision intelligence (DI) is a term that stems from engineering. DI as a science is used to process data with findings from the social sciences and decision theories. The aim is to improve decision-making processes. However, AI should be categorized as a tool and not as a communication partner. AI analyzes information from studies, guidelines, and textbooks from the outset-taking individual patient information into account. Physicians with a high level of clinical expertise can ask more specific questions about the latter. ChatGPT is trained with millions of texts from the internet, social media, online forums, journal articles, and books; it covers almost all areas of life.
    UNASSIGNED: Die künstliche Intelligenz (KI) ist ein Werkzeug, das so gut oder schlecht ist wie deren Nutzer. Beim humanoiden Roboter kann ein KI-System als soziales Gegenüber erscheinen. „Decision intelligence“ (DI, Entscheidungsintelligenz), ist ein Begriff aus den Ingenieurdisziplinen und dient der Verarbeitung von Daten mit Erkenntnissen aus den Sozialwissenschaften und Entscheidungstheorien. Das Ziel ist die Verbesserung von Entscheidungsprozessen. KI ist als Werkzeug einzustufen und nicht als Kommunikationspartner. KI will Informationen aus Studien, Leitlinien und Lehrbüchern von Anfang an analysieren – unter Berücksichtigung individueller Patientendaten, diese kann der Arzt mit hoher klinischer Kompetenz gezielter erfragen. ChatGPT wird mit Millionen von Texten aus dem Internet, sozialen Medien, Online-Foren, Zeitschriftenartikeln und Büchern trainiert, es erfasst fast alle Lebensbereiche.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    由观察健康数据科学与信息学(OHDSI)集体提供的开源软件,包括OMOP-CDM,作为许多现实世界的证据网络和分布式健康数据分析平台的主要支柱。虽然从技术角度来看,容器技术显著简化了部署,监管合规可能仍然是此类平台设置和运行的主要障碍。在本文中,我们提出了OHDSI合规,一套全面的文档模板,旨在简化与数据保护和信息安全相关的文档以及建立OHDSI安装所需的协调工作。
    要确定一组相关文档模板,我们首先分析了法律要求和相关指南,重点是《通用数据保护条例》(GDPR).此外,我们分析了典型的OHDSI堆栈的软件体系结构,并将其组件与所识别的不同一般类型的概念和文档相关联。然后,我们为原型OHDSI安装创建了这些文档,基于所谓的Broadsea包,遵循德国的相关准则。最后,我们通过在需要个别机构特定内容的地方引入占位符和选项来概括文件。
    我们提供四个文件:(1)处理活动的记录,(2)信息安全概念,(3)授权概念,以及(4)涵盖维护堆栈的技术细节的操作概念。这些文件可以在许可许可下公开获得。
    据我们所知,没有其他公开可用的文档集,旨在简化OHDSI部署的合规流程。虽然我们的文件提供了一个全面的起点,需要添加当地细节,and,由于不同国家法律要求的异质性,可能需要进一步收养。
    UNASSIGNED: The open-source software offered by the Observational Health Data Science and Informatics (OHDSI) collective, including the OMOP-CDM, serves as a major backbone for many real-world evidence networks and distributed health data analytics platforms. While container technology has significantly simplified deployments from a technical perspective, regulatory compliance can remain a major hurdle for the setup and operation of such platforms. In this paper, we present OHDSI-Compliance, a comprehensive set of document templates designed to streamline the data protection and information security-related documentation and coordination efforts required to establish OHDSI installations.
    UNASSIGNED: To decide on a set of relevant document templates, we first analyzed the legal requirements and associated guidelines with a focus on the General Data Protection Regulation (GDPR). Moreover, we analyzed the software architecture of a typical OHDSI stack and related its components to the different general types of concepts and documentation identified. Then, we created those documents for a prototypical OHDSI installation, based on the so-called Broadsea package, following relevant guidelines from Germany. Finally, we generalized the documents by introducing placeholders and options at places where individual institution-specific content will be needed.
    UNASSIGNED: We present four documents: (1) a record of processing activities, (2) an information security concept, (3) an authorization concept, as well as (4) an operational concept covering the technical details of maintaining the stack. The documents are publicly available under a permissive license.
    UNASSIGNED: To the best of our knowledge, there are no other publicly available sets of documents designed to simplify the compliance process for OHDSI deployments. While our documents provide a comprehensive starting point, local specifics need to be added, and, due to the heterogeneity of legal requirements in different countries, further adoptions might be necessary.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号